1 Answer
Ranbaxy, an India-based pharmaceutical company, agreed to delay release of its generic version of Lipitor until Nov. 30.
According to its website, Ranbaxy will have the exclusive right to sell its drug in the U.S. for six months.
Experts say when generic versions of these drugs make it to market, pharmaceutical companies could face billions in potential losses, while consumers could save tens of billions of dollars a year.
13 years ago. Rating: 0 | |
Top contributors in Uncategorized category
Unanswered Questions
wi88bmwcom
Answers: 0
Views: 5
Rating: 0
69vncompare
Answers: 0
Views: 6
Rating: 0
pkwinxco
Answers: 0
Views: 6
Rating: 0
Nhà Cái King88
Answers: 0
Views: 8
Rating: 0
sumvipad
Answers: 0
Views: 6
Rating: 0
DA88
Answers: 0
Views: 8
Rating: 0
bk88cx
Answers: 0
Views: 9
Rating: 0
JJJBET Cash-Out Rápido! Aposte Ao Vivo em Futebol e MMA Agora!
> More questions...
Answers: 0
Views: 9
Rating: 0